| Antibodies - Move COVID-19 research forward with Simoa® ultra-sensitive cytokine detection |
|
|
|
|
| |
|
| |
The latest antibodies news from News Medical |
|
|
|
 | | |  Improving SARS-CoV-2 Antibody Detection with Bioluminescence
The Lumit™ Dx SARS-CoV-2 Immunoassay is an IVD test designed to qualitatively detect antibodies to SARS-CoV-2 in serum or plasma. The bioluminescent method used in the assay provides clinical labs with a simple, scalable workflow that is easily automated, taking you from sample to answer in 1 hour.
| |
|
|
|
|
| | |  Since its original discovery, immunofluorescence staining has remained a reliable and powerful technique for a wide range of research and diagnostic purposes. | | | | |  Researchers have recovered and identified the various types of neutralizing antibodies for SARS-CoV-2 from convalescent COVID-19 patients. Of these, they identified three that are extremely potent and could be used to develop treatment therapies. | | | | |  The lack of effective treatments for COVID-19 is forcing hospitals to use blood plasma from recovering patients to treat those who have severe symptoms. | | | | |  One of the most significant questions about the novel coronavirus is whether people who are infected are immune from reinfection and, if so, for how long. | |
|
|
|
|
|
